Shares of Cassava Sciences Inc. dropped over 10% in after-hours trading following a settlement with U.S. securities regulators over misleading claims about an Alzheimer’s clinical trial. The pharma company and two former executives were charged for the deceptive statements, leading to the stock decline. This development highlights the impact of regulatory actions on stock performance in the pharmaceutical sector.
Full Article
Why Shares of Uber Are Surging Today
Shares of Uber (NYSE: UBER) rose approximately 7.6% following the announcement of a partnership with Alphabet's Waymo, allowing users to book Waymo rides exclusively through the Uber app in Atlanta. This marks the second collaboration between the companies, having previously partnered in Austin, where Waymo vehicles have received an average rating of 4.9 stars. Explain It To Me Like I'm 5: Uber's stock went up because they teamed up with Waymo to let people use...
Read more